MedDataX Logo

Anticardiolipin Autoantibodies and Mortality in Septic Patients

NCT ID: NCT04685278

Last Updated: 2020-12-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-10-01

Study Completion Date

2021-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The detection of antiphospholipid antibodies (aPL) is of interest because of their importance in the pathogenesis of arterial or venous thrombosis and their responsibility for a wide spectrum of clinical manifestations such as infection. The aim of the study was to assess the performance of antiphospholipid antibodies biomarker to predict in- hospital mortality in intensive care unit (ICU) septic patient's.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

the investigators conducted a prospective single-center observational study including consecutive critically ill septic adults admitted to the intensive care unit. Clinical and laboratory data including chemiluminescence immunoassay for antiphospholipid antibodies \[anticardiolipin (aCL), antiphosphatidylserine (aPS)\] were obtained. Blood samples were collected on days 1, 3, 5, 8 and 10 of hospitalization. The primary study endpoint was ICU mortality defined as death before ICU discharge. Secondary end points included correlation between SOFA score and biological parameters.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Morality

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

anti-phospholipid sepsis intensive care unit

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood samples

Blood samples were collected in dry tubes on days 1, 3, 5, 8 and 10 of hospitalization

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients, admitted to the ICU for sepsis and older than 18 years

Exclusion Criteria

* pregnancy
* clinical history of antiphospholipid syndrome
* auto-immune diseases
* immunosuppressive treatment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Military Hospital of Tunis

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hajjej Zied

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Iheb Labbene, Pr

Role: STUDY_DIRECTOR

Military Hospital of Tunis

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Military Hospital of Tunisia

Tunis, , Tunisia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Tunisia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Zied Hajjej, Pr

Role: CONTACT

Phone: 0021620358907

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Iheb Labbene, Pr

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Military Hospital of Tunis

Identifier Type: -

Identifier Source: org_study_id